Senior Manager, Regional Access, Germany
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
In this role you will drive the execution of regional and local market access priorities within the national market access strategy, identifying and prioritizing barriers to timely and sustainable patient access. The role will be responsible for providing hands-on support in executing key launch activities across Germany supporting country-level regional and local market access tactics and initiatives to secure reimbursement of Revolution Medicines’ assets. In close cooperation with the sales, marketing, government af
